Amgen's (AMGN) Aimovig Sees Hot Script Growth - RBC
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay notes script growth for Amgen's (NASDAQ: AMGN) Aimovig is positive. MacKay notes 2,129 total scripts ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
